Antisense Arzneimittel gegen das humane interzelluläre Adhäsionsmolekül (ICAM-1)


The present invention relates to a specific antisense oligonucleotide which inhibits the expression of the adhesion molecule ICAM-1 in human cells. The present invention further relates to a vector containing said oligonucleotide and a host cell containing said vector or oligonucleotide and a pharmaceutical composition containing said oligonucleotide as well as uses thereof, in particular in the treatment of an inflammatory disease or condition in humans.
Original languageGerman
Patent numberEP3914710A1
Priority date25.01.19
Priority numberEP19153666.3
Publication statusPublished - 25.01.2019

Cite this